Page 497 - Read Online
P. 497

Page 6 of 9                         Pastor et al. J Cancer Metastasis Treat 2020;6:39  I  http://dx.doi.org/10.20517/2394-4722.2020.57

               Flow cytometry, another valuable quantitative analysis of exosome cargo, is used for exosome capture
               on streptavidin-coated magnetic beads. It was also demonstrated for the collection of CD63+ exosomes
               utilizing biotin-labelled anti-CD63 Ab, starting with fraction number four of exosomes separated by mini-
                   [40]
               SEC . This method demonstrates that the levels of PD-1 and PD-L1 in exosomes obtained from HNSCC
                                                                                                [40]
               patients’ plasma is significantly associated with pathological changes such as disease progression .
               PD-L1 is a ligand with the potential of inducing immune suppression in activated T cells that express
               PD-1. When PD-L1-bearing exosomes were obtained with CD3 and CD69 T lymphocytes, the down-
               regulation of CD69 expression was blocked. Anti-PD1 antibodies inactivate this inhibition. Likewise,
               when plasma-derived exosomes are obtained with activated CD8 T-cells, fast programmed cell death of T
               cells takes place. This reveals that TEX modulate immune cell activity and are able to function as immune
               biomarkers [30,40,41] .

               Clinical analyses need to be simple, reliable and quick. To meet these criteria, we are currently working on
               a new isolation technique using immunoaffinity that allows us to have results in flow cytometry within a
               few hours. This will enable a high-throughput analysis of patient samples.

               One interesting method described could be the photoacoustic and fluorescence flow cytometry platform, as
                                     [28]
               described by Nolan et al. . This is able to perform in vivo flow cytometry on tumor-associated exosomes
               in mouse models. Also, more research is needed to bring this technique into human diagnostics, where it
               seems to be a challenging but promising path.


               Mass spectrometry
               MS is one of the most favorable techniques for proteome characterization, where analytes are converted
               to gaseous ions and are classified recording to their mass-to-charge ratio. It offers various advantages
               such as its specificity, throughput, sensitivity and cost-effective testing. It uses three different proteomic
               MS techniques: digestion by trypsin (bottom-up), digestion by a protein with less-frequent cleavage sites
               (middle-down), and analysis of native protein (top-down). MS has also been linked with ChIP to quantify
               histone modifications, transcription factors and other chromatin-associated proteins.

               As already mentioned above, exosomes contain a variety of functional proteins and genetic cargo such
                                                                          [42]
               as DNA, mRNAs, miRNAs and long non-coding RNAs. Tang et al.  state: “Sucrose density gradients,
               ultrafiltration, high performance liquid chromatography-based protocols and immunoaffinity-capture
               methods, singly or combined with the application of ultracentrifugation, can provide high enrichment and
               purity of exosomes”. Besides, a number of alternative methods for analysis of exosome RNA extraction
               methods have been used: phenol-based techniques (TRIzol) and combined phenol and pure column-based
               techniques. The Total Exosome RNA and Protein Isolation kit (TER) has been particularly selected for
               RNA isolation .
                           [42]
               Global proteomics is an identification method using as many proteins as possible within one sample. There
               are two different strategies: via data dependent acquisition (DDA) or data independent acquisition (DIA),
                                                         [43]
               with DDA being used more commonly than DIA .

               CONCLUSION
               Cancer is one of the biggest challenges of medicine, and we still cannot defeat it as a whole. However, liquid
               biopsy, the analysis of exosomes, ctDNA and CTCs may give us the possibility for non-invasive diagnosis,
               real-time monitoring of disease progression and developing a treatment according to gene profile as well.
               The special features of exosomes make them ideal for minimally invasive liquid biopsy. Exosomes are
               unique; they express not only “dead” particles such as ctDNA but they also show actual biological activity
   492   493   494   495   496   497   498   499   500   501   502